Thromboembolism in patients receiving extracorporeal membrane oxygenation (ECMO) support is a feared complication. Systemic anticoagulation during ECMO in patients with a massively dilated left ventricle (LV) and decreased LV systolic function is still debated. Hearin, we report a case of a 5-month old infant on ECMO support who had fatal thrombus formation in the massively dilated LV and a consequent thromboembolic event.
Citations
Citations to this article as recorded by
Activated Partial Thromboplastin Time Versus Anti-Factor Xa Monitoring of Heparin Anticoagulation in Adult Venoarterial Extracorporeal Membrane Oxygenation Patients Caitlin E. Kulig, Kendra J. Schomer, Hugh B. Black, William E. Dager ASAIO Journal.2021; 67(4): 411. CrossRef
Anticoagulation Therapy during Extracorporeal Membrane Oxygenator Support in Pediatric Patients Hwa Jin Cho, Do Wan Kim, Gwan Sic Kim, In Seok Jeong Chonnam Medical Journal.2017; 53(2): 110. CrossRef